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Pyrene is a regulated pollutant at sites contaminated with polycyclic aromatic hydrocarbons (PAH). It is
mineralized by some bacteria but is also transformed to nonmineral products by a variety of other PAH-
degrading bacteria. We examined the formation of such products by four bacterial strains and identified and
further characterized the most apparently significant of these metabolites. Pseudomonas stutzeri strain P16 and
Bacillus cereus strain P21 transformed pyrene primarily to cis-4,5-dihydro-4,5-dihydroxypyrene (PYRdHD), the
first intermediate in the known pathway for aerobic bacterial mineralization of pyrene. Sphingomonas yanoi-
kuyae strain R1 transformed pyrene to PYRdHD and pyrene-4,5-dione (PYRQ). Both strain R1 and Pseudo-
monas saccharophila strain P15 transform PYRdHD to PYRQ nearly stoichiometrically, suggesting that PYRQ
is formed by oxidation of PYRdHD to 4,5-dihydroxypyrene and subsequent autoxidation of this metabolite. A
pyrene-mineralizing organism, Mycobacterium strain PYR-1, also transforms PYRdHD to PYRQ at high initial
concentrations of PYRdHD. However, strain PYR-1 is able to use both PYRdHD and PYRQ as growth sub-
strates. PYRdHD strongly inhibited phenanthrene degradation by strains P15 and R1 but had only a minor
effect on strains P16 and P21. At their aqueous saturation concentrations, both PYRdHD and PYRQ severely
inhibited benzo[a]pyrene mineralization by strains P15 and R1. Collectively, these findings suggest that prod-
ucts derived from pyrene transformation have the potential to accumulate in PAH-contaminated systems and
that such products can significantly influence the removal of other PAH. However, these products may be sus-
ceptible to subsequent degradation by organisms able to metabolize pyrene more extensively if such organisms
are present in the system.
Polycyclic aromatic hydrocarbons (PAH) are known to be
degradable by a variety of soil bacteria (40). Consequently, the
bioremediation of PAH contamination with naturally occur-
ring microorganisms has been attempted at a number of sites
(43, 45). Most of the interest in the biodegradation of PAH in
the field has been in the removal of the parent compounds,
while most research on pure cultures of PAH-degrading bac-
teria has focused on their ability to grow on or mineralize
specific PAH substrates. Relatively little attention has been
paid to the potential formation of products from the partial
transformation of PAH.
Most of the information that does exist on PAH metabolites
has been obtained in the context of identifying transient me-
tabolites formed by isolates during growth on the parent com-
pound (13, 33, 35, 40) or metabolites formed by mutants of
wild-type degraders (4, 40). Some bacteria, however, are capa-
ble of transforming one or more PAH despite an inability to
grow on or mineralize the PAH in question (1, 20, 31, 47). It is
important to evaluate the products of such incomplete PAH
metabolism because of their potential effects on PAH-degrad-
ing microorganisms or on potentially exposed human popula-
tions (44). Identification of common products of incomplete
metabolism can also be important in assessing the extent to
which natural attenuation may be occurring at contaminated
sites (44).
In a recent study (1), we described the broad PAH substrate
ranges of 11 bacteria isolated from PAH-contaminated soils by
enrichment on phenanthrene as a sole carbon source. None of
these organisms is capable of mineralizing pyrene, yet all could
remove pyrene from solution, and all that were examined fur-
ther transformed pyrene to unidentified metabolites (1). The
objectives of this study were to isolate and identify the major
products from the incomplete metabolism of pyrene by four of
these organisms, evaluate the potential degradability of these
metabolites by an organism known to grow on pyrene as a sole
carbon source, and determine the effects of these metabolites
on the degradation of phenanthrene, a representative growth
substrate for many PAH degraders, and benzo[a]pyrene, a
representative carcinogenic PAH that is not known to serve as
a growth substrate for any organism.
MATERIALS AND METHODS
Chemicals and media. Pyrene (99%), osmium tetroxide (.98%), ruthenium
dioxide (99.9%), sodium periodate (99.8%), and acetone-d6 (99.9%) were ob-
tained from Aldrich (Milwaukee, Wis.). Phenanthrene (.96%), [7-14C]benzo
[a]pyrene (7-14C-labeled BaP) (.98%; specific activity, 26.6 mCi mmol21), and
[4,5,9,10-14C]pyrene (.98%; specific activity, 61 mCi mmol21) were obtained
from Sigma (St. Louis, Mo.). All solvents used were high-pressure liquid chro-
matography (HPLC) grade or the equivalent. Mineral salts buffer (MSB) was as
described in Stucki et al. (39).
cis-4,5-Dihydro-4,5-dihydroxypyrene (PYRdHD) was synthesized by oxidation
of pyrene with osmium tetroxide (10, 23). The crude product was extracted with
200 ml of hexane to remove unreacted pyrene, recrystallized from acetone, and
dried at 50°C for 24 h. The purity of the synthesized compound was established
by the presence of a single peak in chromatograms from HPLC, and the authen-
ticity was established by 1H nuclear magnetic resonance (NMR) spectroscopy.
PYRdHD exhibits UV absorbance maxima at 219 and 261 nm. The 1H NMR
shifts recorded for PYRdHD were (in parts per million) 7.90 (d, 2), 7.84 (s, 2),
7.82 (d, 2), 7.64 (tr, 2), and 5.15 (s, 2).
Pyrene-4,5-dione (PYRQ) was synthesized by the oxidation of pyrene with
ruthenium dioxide and sodium periodate (17). The crude product was dissolved
in 50 ml of methylene chloride and passed through a column of silica gel, which
was eluted successively with hexane (to remove unreacted pyrene) and methyl-
ene chloride. Methylene chloride eluted PYRQ first and then eluted pyrene-1,6-
dione and pyrene-1,8-dione. The purity and authenticity of synthesized PYRQ
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were established by HPLC and 1H NMR spectroscopy, respectively. PYRQ
exhibits UV-visible light absorbance maxima at 238, 295, and 432 nm. The 1H
NMR shifts for PYRQ were (in parts per million) 8.43 (d, 2), 8.38 (d, 2), 8.05 (s,
2), and 7.88 (tr, 2).
Aqueous solubilities of PYRdHD and PYRQ at room temperature were
determined by adding an excess of either compound to 10 ml of MSB in triplicate
vials. After 24 h, the samples were filtered through a 0.02-mm-pore-size alumina
filter (Whatman, Maidstone, England) and analyzed by HPLC. Concentrations
in the filtrate were quantified against external standards of the synthesized
compounds.
Organisms. Pseudomonas saccharophila P15, Pseudomonas stutzeri P16, Bacil-
lus cereus P21, and strain R1 were isolated as described elsewhere (1, 38). Isolate
R1 was identified as a strain of Sphingomonas yanoikuyae by MIDI, Inc. (Newark,
Del.) on the basis of 16S rRNA gene sequence similarity (500-bp analysis; 1.49%
difference from type strain). Mycobacterium PYR-1 was obtained from C.
Cerniglia (National Center for Toxicological Research, Jefferson, Ark.).
Strains P15, P16, P21, and R1 cannot mineralize pyrene but they can all
transform it to non-mineral products (1). They were selected for this study based
on differences in PAH metabolism, as manifested in part by a limited (P16 and
P21) or pronounced (P15 and R1) ability to mineralize benz[a]anthracene, BaP,
and chrysene (1). Strain PYR-1 was selected for its ability to grow on pyrene as
a sole carbon source (26).
Isolation of metabolites. Bacteria were grown in 500 ml of MSB containing 50
mg of phenanthrene, 5 mg of pyrene, and 20 mg (each) of succinate, peptone,
and yeast extract. The cultures were stirred rapidly with a Teflon stir bar for 2
weeks, after which no phenanthrene crystals were visible. The samples were
centrifuged, filtered through a 1.0-mm-pore-size filter, acidified to pH 2.5 with
20% H3PO4, and vacuum extracted through 1 g of octadecyl silica (Supelco,
Bellefonte, Pa.). Retained products were eluted with 20 ml of methanol, which
was evaporated under a gentle stream of N2. The residue was dissolved in 1 ml
of acetone and separated by thin-layer chromatography (TLC) (1000-mm-diam-
eter silica gel, 20 by 20 cm; F254; Whatman) with a 50/50 mixture of hexane and
benzene, followed by a 90/10 mixture of benzene and acetone and finally a
85/10/5 mixture of benzene, acetone, and acetic acid. Bands that fluoresced
strongly under UV light (254 nm) were scraped off the plates, redissolved in
acetone, and filtered through a 0.02-mm-pore-size alumina filter (Whatman).
The filtrates were evaporated under N2, and then the residue was dissolved in
300 ml of acetonitrile and analyzed by HPLC. Injections (150 ml each) were made
on a Supelcosil C18 semipreparative column (25 cm by 10 mm; particle size, 5
mm; Supelco). Fractions were collected manually, and those from each injection
were combined. Then, each fraction was evaporated under N2 and dissolved in
0.5 ml of acetone-d6 for NMR analysis.
Experiments with metabolites. Each organism was grown in 500 ml of MSB
containing 50 mg of phenanthrene (for strains P15, P16, P21, and R1) or 50 mg
of pyrene (for strain PYR-1) for approximately 1 week, centrifuged, and resus-
pended in MSB at an optical density at 420 nm (OD420) of 0.1 unless stated
otherwise. The PAH-degrading activity of washed-cell suspensions of strains P15,
P16, P21, and R1 was verified by measuring the initial rate of phenanthrene
degradation (38) prior to each experiment. Subsequent incubations were con-
ducted in the dark or in amber vessels on a rotary shaker at approximately 150
rpm. When added in a particular assay, synthesized PYRdHD or PYRQ was
provided in a solution of acetone or acetonitrile, which was evaporated prior to
inoculation with cell suspensions.
Metabolite formation from resting cells pregrown on phenanthrene was eval-
uated by incubating a washed-cell suspension (100 ml) in an HPLC vial insert
with approximately 15,000 dpm of [14C]pyrene (1.1 mM) dissolved in 5 ml of
dimethyl sulfoxide (DMSO). Reactions were terminated after 24 h by adding 100
ml of acetonitrile. Samples were analyzed by HPLC, and fractions were collected
every minute with a Waters (Milford, Mass.) fraction collector. Each fraction was
supplemented with 3 ml of scintillation cocktail (ScintiSafe; Fisher Scientific,
Pittsburgh, Pa.) and analyzed with a Tri-Carb 1900TR liquid scintillation ana-
lyzer (Packard, Meriden, Conn.).
An isotope-trapping experiment was conducted with strain P15, in which
washed cells pregrown on phenanthrene were incubated with 50 mM PYRdHD
and [14C]pyrene. A similar experiment was conducted with strains P15 and R1,
in which each strain was incubated with 1.6 mM PYRQ and 20,000 dpm of
14C-labeled BaP. Samples from these experiments were analyzed by radiochro-
matography as described above.
The transformation of PYRdHD to PYRQ was evaluated for each strain by
incubating triplicate washed-cell suspensions (1 ml each) in MSB containing
PYRdHD at concentrations identified below. Reactions were terminated after 3
days by adding 1 ml of acetonitrile, and the supernatants were analyzed by
HPLC.
Effects of pyrene metabolites on the growth of strains P15, P16, P21, and R1
were determined by incubating washed-cell suspensions pregrown on phenan-
threne (OD420 5 0.01) in vials containing 560 mM phenanthrene (added as a
concentrated DMSO solution) alone or with PYRdHD (155 mM) or PYRQ (16
mM). After 3 days, Pierce (Rockford, Ill.) bicinchoninic acid protein assay re-
agent was added to each vial, and the samples were shaken for another 24 h. The
absorbance of the samples at 562 nm was then determined on a Hitachi (Dan-
bury, Conn.) U-3300 spectrophotometer. Protein concentrations were quantified
by comparison to bovine serum albumin standards dissolved in MSB and incu-
bated with the samples for 24 h. No growth occurred in controls containing
DMSO alone.
Growth of strain PYR-1 on PYRdHD or PYRQ as a sole carbon source was
determined with cultures pregrown on pyrene (OD420 5 0.01). PYRdHD or
PYRQ was added to vials at concentrations equivalent to 500 mM, and cultures
were incubated for 4 weeks. Protein concentrations were determined as de-
scribed above.
The effects of pyrene metabolites on phenanthrene degradation rates were
determined with washed cells pregrown on phenanthrene and incubated in MSB
for 24 h to remove any residual phenanthrene. Replicate aliquots (1 ml each)
were then added to empty vials or vials containing PYRdHD or PYRQ at
concentrations equivalent to 155 or 1.6 mM, respectively. Vials were incubated
for 30 min and then supplemented with phenanthrene to a concentration of 5.6
mM. Reactions were terminated by adding 1 ml of acetonitrile at selected inter-
vals up to 20 min, and the remaining concentration of phenanthrene was deter-
mined by HPLC. A first-order (in phenanthrene concentration) degradation rate
equation was fit to the concentration versus time data with Pro-Stat software
(Poly Software International, Sandy, Utah).
The potential reactivity of PYRQ with biomass or buffer constituents was
determined with triplicate washed-cell suspensions (5 ml each) of strain R1 or
P15 in vials containing 10 mM PYRQ. Reactions were terminated after 3 days by
adding 1 ml of acetonitrile, and the supernatants were analyzed for residual
PYRQ by HPLC.
The effects of PYRdHD and PYRQ on BaP mineralization by strains P15 and
R1 were determined with triplicate washed-cell suspensions (5 ml) in 20-ml
scintillation vials containing PYRdHD or PYRQ at concentrations identified
below. Each vial contained a test tube in which a fluted strip of filter paper
soaked with 150 ml of 2 N KOH served as a CO2 trap (1). Approximately 20,000
dpm of 14C-labeled BaP (equivalent to 0.064 mM) was added to each vial, which
was then capped with a Teflon-lined septum. Positive controls did not contain
pyrene metabolites, and uninoculated controls contained 5 ml of MSB supple-
mented with 14C-labeled BaP. Incubations were terminated by injecting 0.5 ml of
20% H3PO4 through the septum. The vials were shaken for an additional 24 h,
and then the filter paper strips were placed in 5 ml of scintillation cocktail and
another 5 ml of scintillation cocktail was added directly to the sample vials.
Samples were analyzed by scintillation counting.
Analyses. HPLC analyses were conducted on a Waters 600E system with a
Supelcosil C18 column (25 cm by 4.6 mm; particle size, 5 mm; Supelco). Pyrene,
PYRdHD, and PYRQ were analyzed with a photodiode array detector and
quantified at 254 nm, and other putative metabolites were analyzed with fluo-
rescence detection (excitation at 259 nm and emission at 370 nm) or photodiode
array detection. The mobile phase for these analyses was initially a 50/50 ratio of
acetonitrile to water containing 0.01% trifluoroacetic acid, which was increased
to 100% acetonitrile over 20 min; these conditions improved the separation of
metabolites compared to analyses performed in earlier work (1). Phenanthrene
was analyzed by detection at 254 nm, with a mobile phase of a 70/30 ratio of
acetonitrile to water containing 0.01% trifluoroacetic acid that was increased
linearly to 100% acetonitrile over 5 min. The 1H NMR spectra were recorded on
a Varian Inova 500 spectrometer at 500 MHz, with shifts reported in parts per
million relative to the proton resonance of tetramethylsilane.
RESULTS
Isolation of pyrene metabolites. Growth of strains P15, P16,
P21, and R1 in a medium containing phenanthrene as a major
carbon source and in the presence of pyrene in excess of its
aqueous solubility resulted in the extracellular accumulation of
a number of pyrene metabolites. The relative quantities of
these metabolites were assessed by the size and strength of the
fluorescent bands on TLC plates. The most significant bands
that were isolated by TLC were purified further by semi-
preparative HPLC, and the purified compounds were analyzed
by 1H NMR spectroscopy.
The most significant metabolite from isolates P16 and P21
was identified as PYRdHD (Fig. 1a), which is the first inter-
mediate in the aerobic bacterial pathway for metabolism of
pyrene (13, 24, 33, 35, 49). PYRdHD was one of two significant
products from strain R1, which also transformed pyrene to
PYRQ (Fig. 1b). No other isolated TLC bands were identified,
including all those from strain P15, either because there were
insufficient amounts for NMR analysis or the NMR spectra
could not be characterized. Optical spectra obtained for the
unidentified bands did not match published spectra of known
intermediates in the bacterial degradation of pyrene (33).
Identification of PYRdHD and PYRQ was confirmed by
comparing the NMR spectra of the bacterial metabolites to
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those of the synthesized compounds as well as published spec-
tra (9, 24, 48). The cis configuration of PYRdHD was estab-
lished by comparison to published 1H NMR spectra of cis and
trans PYRdHD (24). The solubility of PYRdHD in MSB at
room temperature is 155 6 13 mM (36.7 6 3.1 mg/l) and that
of PYRQ is 1.6 6 0.1 mM (0.38 6 0.01 mg/l).
Transformation of [14C]pyrene by resting cells. The radio-
chromatograms of culture fluids from resting cells (Fig. 2)
largely confirmed the results obtained from the transformation
of pyrene during active growth of the organisms on phenan-
threne. On the basis of retention time, resting cells of strains
P16 and P21 transformed pyrene primarily to PYRdHD, and
strain R1 transformed pyrene to PYRQ and a number of other
minor products. Strain P15 removed almost the entire amount
of [14C]pyrene in the 24-h incubation period but did not appear
to form significant amounts of PYRdHD or PYRQ. The ele-
vated baselines in the radiochromatogram for strain P15 after
approximately 8 min (Fig. 2a) indicate the formation of nu-
merous other products, which continued to elute even after the
elution of pyrene. Significant amounts of radiolabel also re-
mained in the empty reaction vials for both strain P15 (approx-
imately 15%) and strain R1 (approximately 30%); in contrast,
the recovery of radiolabel in MSB amended with acetonitrile in
uninoculated controls was approximately 95%. When incu-
bated with [14C]pyrene in the presence of 50 mM PYRdHD,
strain P15 accumulated small amounts of a single product that
eluted at the same retention time as PYRQ (Fig. 2a). Pyrene
removal was considerably slower in the presence of 50 mM
PYRdHD.
Metabolism of PYRdHD and PYRQ. Resting cells of strains
R1 and P15 both converted PYRdHD nearly stoichiometri-
cally to PYRQ, whereas neither strain P16 nor P21 was able
to transform PYRdHD (Table 1). Mycobacterium PYR-1,
an organism known to mineralize pyrene, also transformed
PYRdHD to PYRQ to various extents depending on the initial
concentration of PYRdHD (Table 2). Strain PYR-1 converted
all of the PYRdHD to PYRQ at an initial PYRdHD concen-
tration of 200 mM, whereas at an initial concentration of 50
mM only 4% of the diol was converted to the quinone. This
organism was able to grow on either PYRdHD or PYRQ as a
sole carbon source in MSB medium, as determined by signif-
icant increases in optical density and protein concentration
relative to inoculated vessels with no carbon source (results not
shown). The protein yield from PYRQ was the same as that from
500 mM pyrene under the same conditions, while that from
PYRdHD was about one-third the yield from pyrene or PYRQ.
Effects of pyrene metabolites on phenanthrene degradation.
Apparent first-order rates of phenanthrene degradation were
measured in the presence and absence of PYRdHD and
PYRQ at an initial phenanthrene concentration of 5.6 mM,
which is less than its aqueous solubility. PYRdHD strongly
inhibited phenanthrene degradation by strains P15 and R1,
modestly inhibited phenanthrene degradation by strain P21,
and had a negligible effect on strain P16 (Table 3). PYRQ
strongly inhibited phenanthrene degradation by strain R1 and
had a negligible-to-minor effect on the remaining strains.
In contrast to the observed inhibitory effects of pyrene me-
tabolites on rates of dissolved phenanthrene degradation by
some of the strains, the yield of protein after growth on 560
mM phenanthrene for 3 days in the presence of PYRQ or
PYRdHD was equivalent to the yield obtained after growth on
FIG. 1. Isolated metabolites from pyrene transformation. (a) PYRdHD; (b)
PYRQ.
FIG. 2. Radiochromatograms of culture fluids from 24-hr incubations of
[14C]pyrene with P. saccharophila P15 (a), P. stutzeri P16 (b), B. cereus P21 (c),
and S. yanoikuyae R1 (d). The inset to panel a is the chromatogram from incu-
bation of strain P15 with [14C]pyrene in the presence of 50 mM PYRdHD for
24 h, at which time most of the PYRdHD was depleted; the chromatogram is
truncated before the much larger peak for unreacted pyrene. Solid lines are
sample chromatograms, and dashed lines are chromatograms from uninoculated
controls. PYRdHD, PYRQ, and pyrene eluted at 14, 19, and 29 min, respec-
tively, under the HPLC conditions used to generate these chromatograms.
TABLE 1. Conversion of PYRdHD to PYRQ by
resting cells after 3 days
Strain PYRdHD removed (mM)a PYRQ detected (mM)
P15 21.5 6 0.4 20.6 6 2.1
R1 4.1 6 0.5 3.9 6 0.0
P21 Noneb ,0.5
P16 Noneb ,0.5
a Relative to uninoculated controls, which contained 22.9 6 0.3 mM PYRdHD.
Data are means and standard deviations of triplicate measurements.
b Residual PYRdHD was not significantly different from amount obtained
from controls.
TABLE 2. Concentration dependence of PYRQ formation from





50 ..................................................................................... 2.0 6 1.1
100 ..................................................................................... 18 6 13
200 ..................................................................................... 205 6 37
a All of the added PYRdHD (98.7% 6 6.8%) was recovered in uninoculated
vials. No PYRdHD was recovered in any of the sample vials. Data are means and
standard deviations of triplicate measurements.
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phenanthrene alone for all four strains (not shown). There was
no growth on PYRQ or PYRdHD by any of these isolates.
Effects of pyrene metabolites on mineralization of BaP. Both
PYRdHD and PYRQ at concentrations near their aqueous
saturation concentrations strongly inhibited the mineralization
of BaP by strains P15 and R1 throughout a 48-h incubation
period (Fig. 3). In addition, PYRQ inhibited BaP mineraliza-
tion by both strains at concentrations lower than its aqueous
saturation concentration over a 48-h incubation (Table 4).
Radiochromatograms of culture fluids from incubation of ei-
ther organism with 1.6 mM PYRQ indicated that no metabo-
lites accumulated and less BaP was removed than in positive
controls incubated without PYRQ (not shown).
DISCUSSION
The ability of PAH-degrading organisms to transform PAH
that they are incapable of mineralizing has been noted previ-
ously (1, 20, 31, 47), but the products of such incomplete
metabolism have not been characterized. Partial transforma-
tion of pyrene may be particularly relevant because of an
apparently limited diversity in the ability of PAH-degrading
bacteria to mineralize pyrene. The ability to grow on or min-
eralize pyrene is primarily associated with actinomycetes (25,
26), whereas a diverse group of bacteria isolated from PAH-
contaminated soils by enrichment with phenanthrene can re-
move pyrene without mineralizing it (1).
Pyrene transformation by P. stutzeri P16 and B. cereus P21
during active growth on phenanthrene leads to the formation
of significant amounts of PYRdHD as an apparently terminal,
or “dead-end,” metabolite. PYRdHD has been identified as an
intermediate in the degradation of pyrene by a number of
strains that can grow on or mineralize pyrene (13, 24, 33, 35,
49). It also has been found in pyrene-contaminated marine
sediments (30) and has accumulated when pyrene was added to
enrichment cultures derived from the sediment (29). The for-
mation of a cis-dihydrodiol from pyrene is consistent with its
oxidation via a PAH dioxygenase, an enzyme class for which
examples from several bacteria are known to have broad sub-
strate ranges (14, 15, 18, 27, 28, 34, 37, 46).
When grown on phenanthrene in the presence of pyrene,
S. yanoikuyae R1 accumulated significant amounts of PYRdHD
and PYRQ in the medium, although only PYRQ was detected
when [14C]pyrene was incubated with resting cells (Fig. 2d).
Formation of PYRQ probably proceeds by subsequent metab-
olism of PYRdHD, as both strains R1 and P15 converted
PYRdHD essentially stoichiometrically to PYRQ (Table 1).
PYRQ has not been observed previously as an intermediate in
the degradation of pyrene, but o-quinones such as PYRQ can
arise from the autoxidation of an o-dihydroxy intermediate (7,
12, 32). We were not able to isolate 4,5-dihydroxypyrene, nor
has it been isolated in previous work with pyrene-degrading
organisms. Since 4,5-dihydroxypyrene is rapidly oxidized to
PYRQ in air at ambient conditions (41), PYRQ presumably
results from the autoxidation of 4,5-dihydroxypyrene.
P. saccharophila P15 can convert PYRdHD to PYRQ, but
neither metabolite was identified in either growing- or resting-
cell incubations of this organism with pyrene. The radiochro-
matograms from resting cell incubations of strains P15 and R1
(Fig. 2) indicate that other nonmineral products were formed
by these organisms. We do not believe that these other prod-
ucts are metabolites further down the known pyrene degra-
dation pathway, such as phenanthrene-dicarboxylic acid or
phenanthrene-carboxylic acid. When the HPLC conditions
used to analyze culture fluids were optimized for the fluo-
rescence detection of the phenanthrene aromatic skeleton,
no such peaks were detected in culture fluids from any of
the strains. In addition, degradation beyond phenanthrene-
FIG. 3. Mineralization of BaP by P. saccharophila P15 (a) and S. yanoikuyae
R1 (b). Each strain was incubated alone (Œ) or in the presence of 155 mM
PYRdHD (F) or 1.6 mM PYRQ (E). Data are means and standard deviations of
triplicate measurements at each time point. Unobservable error bars are within
the size of the symbol. Total recoveries of 14C ranged from 79 to 99% for strain
P15 and from 95 to 99% for strain R1.
TABLE 3. Effects of pyrene metabolites on apparent rates
of phenanthrene degradation
Strain
Apparent phenanthrene degradation rate in
the presence of the indicated metabolite (min21)a
None PYRdHD PYRQ
P15 0.10 6 0.032 0.005 6 0.0005 0.10 6 0.04
P16 0.14 6 0.04 0.12 6 0.03 0.13 6 0.04
P21 0.23 6 0.03 0.15 6 0.03 0.16 6 0.03
R1 0.14 6 0.07 0.02 6 0.02 0.01 6 0.01
a Best-fit first-order degradation coefficients and the associated 95% confi-
dence interval.
TABLE 4. Effect of PYRQ concentration on the mineralization
of BaP by strains P15 and R1a
PYRQ added
(mM)
% of added dpm as CO2
after 48 h in strain
P15 R1
None 52 6 2.1 25 6 1.8
0.16 45 6 1.4 3.7 6 0.1
0.8 19 6 2.6 1.2 6 0.1
1.6 8.0 6 1.7 1.0 6 0.1
Uninoculated control (1.6 mM) 0.4 6 0.2 0.1 6 0.1
a Data are means and standard deviations of triplicate measurements. Total
recoveries of 14C ranged from 83 to 90% for strain P15 and from 88 to 98% for
strain R1. Total recoveries in the uninoculated controls were 93 and 98%,
respectively.
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dicarboxylic acid should result in the formation of 14CO2,
since the [14C]pyrene used in these experiments is labeled at
the 4,5 position.
When isotope trapping with PYRdHD was used to examine
the transformation of pyrene by strain P15, a single product
accumulated that elutes at the same retention time as PYRQ
(Fig. 2a). This result, and the relatively facile oxidation of
PYRdHD to PYRQ by this organism, suggests that pyrene
metabolism by strain P15 probably does proceed via oxida-
tion at the 4,5 bond. When incubated with a large excess of
PYRdHD, intracellular concentrations of 4,5-dihydroxypyrene
are likely to be far greater than during the metabolism of
pyrene alone. Under these conditions, the autoxidation of 4,5-
dihydroxypyrene could be favored over other reactions in
which this intermediate may be involved.
The unidentified products from pyrene transformation by
strain P15 (and possibly strain R1) most likely represent ad-
ducts from the reaction of one or more pyrene metabolites
with cellular constituents. The formation of such adducts is
consistent with the presence of an insoluble residue when both
strains were incubated with radiolabeled pyrene. Based on the
accumulation of PYRQ in the isotope-trapping experiment,
the reactive metabolite may be pyrene-4,5-dihydriodiol or a
reactive intermediate derived from its intracellular oxidation.
We rule out covalent reaction of PYRQ with cellular or buffer
constituents, even though o-quinones derived from naphtha-
lene and BaP can form conjugates in phosphate and glycine
buffers and can also form adducts with nucleophiles such as
cysteine and glutathione (32). We recovered 100% of the
added PYRQ incubated with strains P15 or R1 for 3 days (not
shown), and PYRQ also accumulated stoichiometrically with
the removal of PYRdHD by these organisms.
Mycobacterium PYR-1 surprisingly formed significant amounts
of PYRQ when incubated with a high concentration of PYRdHD,
although it was not formed when strain PYR-1 was grown on
pyrene. Similar to the isotope-trapping experiment with strain
P15, it is likely that the rate of formation of 4,5-dihydroxy-
pyrene at high concentrations of PYRdHD exceeds the subse-
quent rate of metabolism, resulting in the accumulation of 4,5-
dihydroxypyrene and its consequent autoxidation to PYRQ. A
similar phenomenon has been noted before in the bacterial
degradation of naphthalene, for which the accumulation of
naphthoquinone has been suggested to increase as the rate of
naphthalene availability increased (2, 19). Strain PYR-1 is able
to consume PYRQ as a growth substrate, which suggests that
it would only accumulate transiently if formed by this organism
or by other bacteria that might also be transforming pyrene in
a complex system. It would be of interest to know if other or-
ganisms capable of growing on or mineralizing pyrene are able
to degrade PYRQ, as our work suggests that PYRQ has the
potential to accumulate in PAH-contaminated systems that
contain organisms incapable of more extensive pyrene metab-
olism.
Effects of pyrene metabolites on the degradation of other PAH.
The present study clearly demonstrated that extracellular
metabolites from the partial transformation of one PAH
substrate can adversely affect the metabolism of other PAH.
Both PYRdHD and PYRQ led to decreased rates of phenan-
threne degradation by at least one of the organisms tested (Ta-
ble 3). These effects did not appear to result from irreversible
reactions of the metabolites or reactive species derived from
them, since neither metabolite inhibited the growth of any
strain when phenanthrene was present as a sole carbon source
in excess of its aqueous solubility.
The ability of PYRdHD and PYRQ to virtually block BaP
mineralization by both strains P15 and R1 (Fig. 3) is important,
as BaP appears to be particularly recalcitrant in contaminated
soil systems (5, 11, 21). Cornelissen et al. (11) have suggested
that the recalcitrance of BaP and other high-molecular-weight
PAH in contaminated soils is due to unexplained biological
factors rather than to limitations in the bioavailability of these
compounds. Combined with the possibility that BaP degrada-
tion can be much slower than that of other PAH (8), the ac-
cumulation of inhibitory metabolites could lead to long-term
persistence in PAH-contaminated systems.
The mechanisms of inhibition by pyrene metabolites ob-
served in this study are not apparent. It is possible that
PYRdHD could competitively inhibit a dihydrodiol dehydro-
genase utilized in the degradation of BaP or phenanthrene by
strains P15 and R1, as it clearly is a substrate for these organ-
isms. Alternatively, PYRdHD could inhibit BaP mineralization
via the formation of PYRQ, which also inhibited BaP miner-
alization by strains P15 and R1. As discussed above, PYRQ
does not appear to react covalently with cellular constituents,
although it is possible that only a small concentration of PYRQ
is required to react with a critical enzyme or other constituent.
However, in this case we would expect inhibition to be inde-
pendent of PYRQ concentration, since PYRQ would be pres-
ent in large excess at all concentrations. This was clearly not
the case in the mineralization of BaP (Table 4). We also rule
out competitive effects of PYRQ as an explanation for the
inhibition of BaP oxidation; we would have expected such
competition to lead to the accumulation of BaP metabolites,
but this was not observed with radiochromatography. A possi-
ble explanation for the inhibitory effects of PYRQ is its poten-
tial to mediate futile redox reactions that could alter the bal-
ance of vital redox cofactors, as has been observed for other
PAH o-quinones (32).
Other considerations. The potential fates of extracellular
metabolites such as PYRdHD and PYRQ in a contaminated
soil or sediment system are important to consider. Microbial
consortia can lead to more extensive degradation of PAH than
can be achieved with pure cultures (6, 42), and in some cases
such consortia can degrade metabolites that otherwise would
accumulate (6, 29). If pyrene-mineralizing organisms are not
present in systems in which pyrene metabolites accumulate to
inhibitory levels, it may be possible to enhance overall PAH
degradation by inoculating the system with organisms capable
of degrading the metabolites.
Abiotic reactions of pyrene metabolites with soil constitu-
ents, particularly natural organic matter (NOM), may also be
important. Radiolabel originating from [14C]pyrene has been
shown to interact with NOM at long incubation times in soil
(22), and quinones are known to undergo oxidation-reduction
reactions with NOM (36). Furthermore, the aqueous solubility
of PYRQ (0.37 mg/l) is 2 orders of magnitude lower than that
of PYRdHD; thus, PYRQ has the potential to precipitate in
some systems, which might influence its subsequent degrada-
tion. The potential accumulation of o-quinones derived from
PAH in contaminated systems also needs to be evaluated from
a human risk assessment standpoint, since a variety of such
o-quinones have been shown to be cytotoxic and mutagenic
and to form DNA adducts in mammalian cells (32). Transient
increases in mutagenicity and toxicity have been observed in
PAH-contaminated soils undergoing active bioremediation (3,
16), which might be explained by the presence of PAH metab-
olites such as those described here.
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